Status:
TERMINATED
Observational Study of Cardiovascular Disease.
Lead Sponsor:
University of Sydney
Collaborating Sponsors:
The TIMI Study Group
Imperial College London
Conditions:
Cardiovascular Diseases
Cardiovascular Morbidity
Eligibility:
All Genders
Brief Summary
This observational study will follow participants who completed follow-up in the FOURIER OUTCOMES trial to evaluate the long-term effects of evolocumab treatment. Long-term post-trial (legacy) benefic...
Eligibility Criteria
Inclusion
- Subjects who completed the FOURIER OUTCOMES trial (defined as attendance at close-out visit irrespective of treatment compliance) will be approached by FOURIER OUTCOMES site investigators and asked about their interest in taking part in this trial.
Exclusion
Key Trial Info
Start Date :
February 5 2020
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
April 26 2021
Estimated Enrollment :
1137 Patients enrolled
Trial Details
Trial ID
NCT04128475
Start Date
February 5 2020
End Date
April 26 2021
Last Update
April 8 2024
Active Locations (3)
Enter a location and click search to find clinical trials sorted by distance.
1
TIMI Study Group
Boston, Massachusetts, United States, 02115
2
Oslo University Hospital
Nydalen, Oslo County, Norway, 0424
3
Imperial College London
London, United Kingdom